Muscinil (Procyclidine Hydrochloride)

Procyclidine Hydrochloride, the active ingredient in Muscinil, is an anticholinergic (muscarinic antagonist) presented as an oral formulation for oral use. It treats Parkinson's disease and drug‑induced extrapyramidal symptoms, including akathisia, in adult patients. GNH USA supplies Muscinil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Muscinil is an anticholinergic agent used in movement‑disorder management and related drug‑induced conditions. - Parkinson's disease: improves motor control by reducing central cholinergic overactivity. - Drug‑induced extrapyramidal symptoms: alleviates rigidity, tremor and dystonia caused by antipsychotic therapy. - Akathisia: reduces restlessness and the urge to move in patients experiencing this side effect.

Common Side Effects: - Dry mouth: reduced salivary secretion leading to thirst. - Blurred vision: caused by pupil dilation. - Constipation: slowed gastrointestinal motility. - Urinary retention: difficulty initiating urination. - Dizziness: sensation of light‑headedness. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Confusion: altered mental status, especially in the elderly. - Hallucinations: visual or auditory disturbances. - Severe tachycardia: rapid heart rate requiring medical attention. - Allergic reactions: rash, itching, or angioedema. - Acute glaucoma: sudden eye pain and vision loss. - Neuroleptic malignant‑like syndrome: rare but life‑threatening condition.

Before initiating therapy, clinicians should consider several safety aspects. - Assess renal function: adjust dosing in severe impairment. - Monitor anticholinergic burden: especially in elderly patients prone to cognitive effects. - Avoid use in narrow‑angle glaucoma: may precipitate acute angle‑closure attacks. - Caution in cardiac arrhythmias: may increase heart rate and provoke rhythm disturbances. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Procyclidine may interact with several drug classes, requiring careful management. Major Interactions (Avoid): - Concurrent anticholinergics: additive anticholinergic toxicity. - MAO inhibitors: enhanced central nervous system effects. - QT‑prolonging agents: increased risk of cardiac arrhythmias. Moderate Interactions (Monitor Closely): - Antihistamines: may increase sedation and anticholinergic load. - Opioids: potentiation of constipation and reduced gastrointestinal motility.